BINSA Act
Biotechnology moves into the DPA’s prohibited/notifiable framework, tightening review and restrictions on cross-border biotech licensing, JV, and equity transactions.
Biotechnology moves into the DPA’s prohibited/notifiable framework, tightening review and restrictions on cross-border biotech licensing, JV, and equity transactions.
WeVote — Public opinion
No community votes yet. Be the first to weigh in from the Vote tab.
Versions
Bill text & amendments
The official bill text and any amendments will be posted here once available.